LYEL Lyell Immunopharma Net earnings per share growth this year

LYEL (Lyell Immunopharma) - company brandmark

The relative EPS YoY trend for Lyell Immunopharma (LYEL) reflects the dynamics of T-cell reprogramming and success in solid tumor therapy, with the metric holding at 58.10. However, high operating losses and early-stage development risks necessitate a constant influx of capital. Business stability is supported by a streamlined ultra-fast air delivery network for biomaterials, which eliminates supply chain disruptions.

Lyell Immunopharma, Inc. (LYEL): Net earnings per share growth this year from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company Lyell Pharma (LYEL)

- current quotes and average value forecast:
Summary company analysis:LYEL (Lyell Immunopharma)
Brand item of Lyell Immunopharma Inc

For the biotechnology sector, where Lyell Immunopharma (LYEL) is developing methods to combat solid tumors, this indicator reflects the year-over-year dynamics of net earnings per share. Analyzing the relative EPS growth over 12 months allows for an assessment of the efficiency of innovation capitalization through the percentage change in yield, determining the company's ability to transform scientific developments into sustainable financial profit.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year IPHA|PYXS - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year